FDA Adverse Event
Injury
Summary report: N
REVANESSE VERSA+ 1.2 ML
MDR report key: 17007659
·
Received May 25, 2023
Report
- Report Number
- 3004423487-2023-00017
- Event Type
- Injury
- Date Received
- May 25, 2023
- Date of Event
- February 7, 2023
- Report Date
- May 25, 2023
- Manufacturer
- PROLLENIUM MEDICAL TECHNOLOGIES INC., AURORA, ON,
- Product Code
- LMH
- UDI-DI
- 10669808001038
- PMA / PMN Number
- P160042 S004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- 117
Narratives
Description of Event or Problem · 0
ON (B)(6) 2023, A PATIENT WAS INJECTED WITH 0.8 ML OF REVANESSE VERSA+ HA FILLER INTO THEIR LIPS. A TOPICAL ANESTHETIC WAS USED, OINTMENT LIDOCAINE 23%, TETRACAINE 7%, LIPS. PATIENT HAD A VIRAL INFECTION AND WAS IN BED FOR 2-3 DAYS. SHE NOTICED HER LIPS GOT SWOLLEN AND FORMED 2 LITTLE LUMPS. NO TREATMENT WAS GIVEN. SHE JUST MONITORED IT. IN A COUPLE OF DAYS WHEN SHE WAS FEELING BETTER, THE LIPS WERE NO LONGER SWOLLEN AND THE NODULES WENT AWAY. PROLLENIUM MEDICAL TECHNOLOGIES INC. WILL CONTINUE THE INVESTIGATION. INTERNAL REPORT NUMBER: (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1640117 | REVANESSE VERSA+ 1.2 ML | REVANESSE VERSA+ | LMH | PROLLENIUM MEDICAL TECHNOLOGIES INC., AURORA, ON, | 40083 | 10669808001038 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 27 YR | Female |